These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27682516)

  • 21. Biomarkers in the critically ill patient: procalcitonin.
    Reinhart K; Meisner M
    Crit Care Clin; 2011 Apr; 27(2):253-63. PubMed ID: 21440200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased serum procalcitonin levels are not specific to sepsis in neonates.
    Monneret G; Labaune JM; Isaac C; Bienvenu F; Putet G; Bienvenu J
    Clin Infect Dis; 1998 Dec; 27(6):1559-61. PubMed ID: 9868696
    [No Abstract]   [Full Text] [Related]  

  • 23. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
    Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
    Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Procalcitonin--a specific marker for severe bacterial infection and sepsis].
    Elbirt D; Frenkel Rubin M; Ergaz D; Sthoeger Z
    Harefuah; 2001 Apr; 140(4):343-6. PubMed ID: 11303402
    [No Abstract]   [Full Text] [Related]  

  • 25. Procalcitonin: THE marker of sepsis?
    Vincent JL
    Crit Care Med; 2000 Apr; 28(4):1226-8. PubMed ID: 10809314
    [No Abstract]   [Full Text] [Related]  

  • 26. Endothelial cell-specific molecule-1/endocan: Diagnostic and prognostic value in patients suffering from severe sepsis and septic shock.
    Pauly D; Hamed S; Behnes M; Lepiorz D; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
    J Crit Care; 2016 Feb; 31(1):68-75. PubMed ID: 26489483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procalcitonin in diagnosis of severe infections.
    Al-Nawas B; Krammer I; Shah PM
    Eur J Med Res; 1996 Apr; 1(7):331-3. PubMed ID: 9364034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Procalcitonin: a new marker of bacterial infection. Importance and prospects].
    Bohuon C; Gendrel D
    Arch Pediatr; 1999 Feb; 6(2):141-4. PubMed ID: 10079881
    [No Abstract]   [Full Text] [Related]  

  • 29. Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot study.
    Ruiz-Rodríguez JC; Caballero J; Ruiz-Sanmartin A; Ribas VJ; Pérez M; Bóveda JL; Rello J
    Med Intensiva; 2012 Oct; 36(7):475-80. PubMed ID: 22257436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers for pediatric sepsis and septic shock.
    Standage SW; Wong HR
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):71-9. PubMed ID: 21171879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is procalcitonin a reliable marker of sepsis in critically ill septic patients undergoing continuous veno-venous hemodiafiltration with "high cut-off" membranes (HCO-CVVHDF)?
    Caldini A; Chelazzi C; Terreni A; Biagioli T; Giannoni C; Villa G; Messeri G; De Gaudio AR
    Clin Chem Lab Med; 2013 Jun; 51(11):e261-3. PubMed ID: 23787472
    [No Abstract]   [Full Text] [Related]  

  • 32. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial.
    Oliveira CF; Botoni FA; Oliveira CR; Silva CB; Pereira HA; Serufo JC; Nobre V
    Crit Care Med; 2013 Oct; 41(10):2336-43. PubMed ID: 23921272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin Is Not a Useful Biomarker of Sepsis.
    Talan DA
    Ann Emerg Med; 2015 Sep; 66(3):320-1. PubMed ID: 26304252
    [No Abstract]   [Full Text] [Related]  

  • 34. [Procalcitonin as a marker for severe sepsis in an immunosuppressed patient].
    Axer H; Wohlfarth M; Meisner M; Finn S; Ragoschke-Schumm A; Mentzel HJ; Witte OW; Isenmann S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Feb; 40(2):97-102. PubMed ID: 15714400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procalcitonin levels in schizophrenic patients and patients with sepsis.
    de Campos SM; Barbosa IG; Ribeiro-Santos R; Ferretjans R; Cruz BF; Oliveira CF; Oliveira Alves CR; Nobre V; Salgado JV; Teixeira AL
    Schizophr Res; 2015 Oct; 168(1-2):575-6. PubMed ID: 26194992
    [No Abstract]   [Full Text] [Related]  

  • 36. [Procalcitonin--acute inflammatory marker in infections].
    Tvede M
    Ugeskr Laeger; 2004 Oct; 166(43):3795. PubMed ID: 15544106
    [No Abstract]   [Full Text] [Related]  

  • 37. Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?
    Iapichino G; Marzorati S; Umbrello M; Baccalini R; Barassi A; Cainarca M; Colombo Pavini F; Mantovani E; Mauri A; Moroni B; Noto A; Melzi D'Eril GV; Langer M
    Minerva Anestesiol; 2010 Oct; 76(10):814-23. PubMed ID: 20935617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin mode of action: new pieces in a complex puzzle.
    Russwurm S; Reinhart K
    Crit Care Med; 2004 Aug; 32(8):1801-2. PubMed ID: 15286570
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnostic value of procalcitonin in sepsis in the elderly].
    Zhang L; Wang YO; Wang DH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jun; 16(6):360. PubMed ID: 15182451
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.
    Yin Q; Liu B; Chen Y; Zhao Y; Li C
    Thromb Res; 2013 Oct; 132(4):471-6. PubMed ID: 24035044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.